| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |